A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension
Robyn J. Barst(Columbia University), David Wessel(Children's National), D. Dunbar Ivy(University of Colorado Denver), Marjana Serdarevic-Pehar(Jagiellonian University), András Szatmári(Walsh University), Gary Layton(Jagiellonian University), Tomás Pulido(Instituto Nacional de Cardiología), Alberto E. García(Jagiellonian University), Guillermo Gaitan(Jagiellonian University), B.K.S. Sastry(Jagiellonian University), Andrzej Rudziński(Jagiellonian University)
Cited by 374
Related Papers
Survival in Patients with Primary Pulmonary Hypertension
|Annals of Internal Medicine|1991|3.5k
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k
Pediatric Pulmonary Hypertension
|Circulation|2015|1.1k